Cardiotoxic and Dyslipidemic Effects of Doxorubicin and Betulinic Acid Amide


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Changes in the blood lipid spectrum and structural reorganization of the rat myocardium in response to injection of a single sublethal dose of doxorubicin (7 mg/kg) alone and in combination with course administration of betulonic acid amide (100 mg/kg/day for 14 days) were studied. Betulinic acid amide in the specified dose exhibited less pronounced cardiotoxic (necrobiotic impairment of cardiomyocytes) and dyslipidemic (increase of cholesterol and triglyceride levels) effects in comparison with doxorubicin. Combined treatment with betulinic acid amide and doxorubicin led to more pronounced remodeling of the myocardium, which was shown by a significant increase of the connective tissue/cardiomyocyte volume ratio detected by day 14 of the experiment.

About the authors

M. G. Klinnikova

Institute of Molecular Pathology and Pathomorphology; N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Division of the Russian Academy of Sciences

Author for correspondence.
Email: pathol@inbox.ru
Russian Federation, Novosibirsk

E. L. Lushnikova

Institute of Molecular Pathology and Pathomorphology; N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Division of the Russian Academy of Sciences

Email: pathol@inbox.ru
Russian Federation, Novosibirsk

E. V. Koldysheva

Institute of Molecular Pathology and Pathomorphology; N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Division of the Russian Academy of Sciences

Email: pathol@inbox.ru
Russian Federation, Novosibirsk

T. G. Tolstikova

Institute of Molecular Pathology and Pathomorphology; N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Division of the Russian Academy of Sciences

Email: pathol@inbox.ru
Russian Federation, Novosibirsk

I. V. Sorokina

Institute of Molecular Pathology and Pathomorphology; N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Division of the Russian Academy of Sciences

Email: pathol@inbox.ru
Russian Federation, Novosibirsk

E. I. Yuzhik

Institute of Molecular Pathology and Pathomorphology; N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Division of the Russian Academy of Sciences

Email: pathol@inbox.ru
Russian Federation, Novosibirsk

M. M. Mzhelskaya

Institute of Molecular Pathology and Pathomorphology; N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Division of the Russian Academy of Sciences

Email: pathol@inbox.ru
Russian Federation, Novosibirsk


Copyright (c) 2016 Springer Science+Business Media New York

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies